N6-Methyladenosine modification: a novel pharmacological target for anti-cancer drug development
N6-Methyladenosine (m6A) modification is the most pervasive modification of human mRNA molecules. It is reversible via regulation of m6A modification methyltransferase, demethylase and proteins that preferentially recognize m6A modification as “writers”, “erasers” and “readers”, respectively. Altere...
Main Authors: | Yi Niu, Arabella Wan, Ziyou Lin, Xiongbin Lu, Guohui Wan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-10-01
|
Series: | Acta Pharmaceutica Sinica B |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383518302478 |
Similar Items
-
RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3
by: Yi Niu, et al.
Published: (2019-03-01) -
Landscape of N6-Methyladenosine Modification Patterns in Human Ameloblastoma
by: Xing Niu, et al.
Published: (2020-10-01) -
Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
by: Qinghai Li, et al.
Published: (2021-02-01) -
Epigenetic regulation of N6‐methyladenosine modifications in obesity
by: Mingli Sun, et al.
Published: (2021-08-01) -
The functions of N6-methyladenosine modification in lncRNAs
by: Rong-Zhang He, et al.
Published: (2020-12-01)